167 related articles for article (PubMed ID: 11774567)
1. Gene therapy of severe combined immunodeficiencies.
Fischer A; Hacein-Bey S; Le Deist F; De Saint Basile G; Cavazzana-Calvo M
Adv Exp Med Biol; 2001; 495():199-204. PubMed ID: 11774567
[No Abstract] [Full Text] [Related]
2. X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years.
Leonard WJ
Mol Med Today; 2000 Oct; 6(10):403-7. PubMed ID: 11006530
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.
Cavazzana-Calvo M; Hacein-Bey S; de Saint Basile G; Gross F; Yvon E; Nusbaum P; Selz F; Hue C; Certain S; Casanova JL; Bousso P; Deist FL; Fischer A
Science; 2000 Apr; 288(5466):669-72. PubMed ID: 10784449
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and immunodeficiency diseases.
Leonard WJ
Nat Rev Immunol; 2001 Dec; 1(3):200-8. PubMed ID: 11905829
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy of severe combined immunodeficiencies.
Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
J Gene Med; 2001; 3(3):201-6. PubMed ID: 11437325
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy of severe combined immunodeficiencies.
Fischer A; Hacein-Bey S; Le Deist F; Soudais C; Di Santo JP; de Saint Basile G; Cavazzana-Calvo M
Immunol Rev; 2000 Dec; 178():13-20. PubMed ID: 11213798
[TBL] [Abstract][Full Text] [Related]
7. A new chance for SCID gene therapy.
Bordignon C
Nat Med; 1998 Jan; 4(1):19-20. PubMed ID: 9427599
[No Abstract] [Full Text] [Related]
8. Successful gene therapy for severe combined immunodeficiency.
Rosen FS
N Engl J Med; 2002 Apr; 346(16):1241-3. PubMed ID: 11961154
[No Abstract] [Full Text] [Related]
9. Gene therapy for XSCID: the first success of gene therapy.
Kohn DB
Pediatr Res; 2000 Nov; 48(5):578. PubMed ID: 11044472
[No Abstract] [Full Text] [Related]
10. [Gene therapy of severe combined immunodeficiencies].
Cavazzana-Calvo M; Hacein-Bey S; de Saint-Basile G; Le Deist F; Fischer A
Transfus Clin Biol; 2000 Jun; 7(3):259-60. PubMed ID: 10919216
[No Abstract] [Full Text] [Related]
11. [Gene therapy of X-linked severe combined immunologic deficiency (SCID-X1)].
Hacein-Bey S; Gross F; Nusbaum P; Yvon E; Fischer A; Cavazzana-Calvo M
Pathol Biol (Paris); 2001 Feb; 49(1):57-66. PubMed ID: 11265225
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy. The best of times, the worst of times.
Anderson WF
Science; 2000 Apr; 288(5466):627-9. PubMed ID: 10799000
[No Abstract] [Full Text] [Related]
13. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency.
White H; Thrasher A; Veys P; Kinnon C; Gaspar HB
Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387
[TBL] [Abstract][Full Text] [Related]
14. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
[TBL] [Abstract][Full Text] [Related]
16. Early peripheral T-cell expansion after haploidentical CD34(+) peripheral blood progenitor cell transplantation (PBPCT) with T-cell depletion in a patient with X-linked SCID: case report.
Kałwak K; Gorczyńska E; Toporski J; Turkiewicz D; Rybka B; Bogusławska-Jaworska J
Transplant Proc; 2000 Sep; 32(6):1409-11. PubMed ID: 10995997
[No Abstract] [Full Text] [Related]
17. Evolving Gene Therapy in Primary Immunodeficiency.
Thrasher AJ; Williams DA
Mol Ther; 2017 May; 25(5):1132-1141. PubMed ID: 28366768
[TBL] [Abstract][Full Text] [Related]
18. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH
J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149
[TBL] [Abstract][Full Text] [Related]
19. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
20. In vivo competitive studies between normal and common gamma chain-defective bone marrow cells: implications for gene therapy.
Otsu M; Sugamura K; Candotti F
Hum Gene Ther; 2000 Sep; 11(14):2051-6. PubMed ID: 11020803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
